Product Information

FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Avenacy Inc., priced at $0.5291 per ML under NDC 83634030202. Its NADAC has been published 105 times since Nov 13, 2024.

FDA first approved this application on Aug 26, 2014. Its Orange Book therapeutic-equivalence code is AP.

FUROSEMIDE 20 MG/2 ML VIAL

furosemide
$0.5291per ML

Strength

10 mg/mL

Manufacturer

Avenacy Inc.

NDC

83634030202

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

FUROSEMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203428

FDA Approved

8/26/2014

TE Code

AP

On Market Since

3/15/2024

Pharmacological Classes

Increased Diuresis at Loop of Henle
Loop Diuretic

Price Statistics

The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 105 times since Nov 13, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.5291 per ML
All-time high$0.5291 (Nov 11, 2026)
All-time low$0.3473 (Dec 17, 2025)
52-week high$0.5291
52-week low$0.3473
Median price$0.4073
Average price$0.4119
Largest weekly change-22.5% (Dec 18, 2024)
Weeks tracked105
Tracking sinceNov 13, 2024

Price History

1W

0.0%

1M

+7.9%

3M

+22.6%

6M

+27.3%

1Y

+44.4%

3Y

N/A

5Y

N/A

All

+0.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Avenacy Inc., is $0.5291 per ML (NDC 83634030202), effective Nov 11, 2026.

How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has held within roughly two percent of its current level. It has been tracked across 105 weekly CMS publications since Nov 13, 2024.

What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?

Since Nov 13, 2024, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Dec 17, 2025) to a high of $0.5291 (Nov 11, 2026), with a median of $0.4073 per ML.

Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2334 per ML — about 56% below FUROSEMIDE 20 MG/2 ML VIAL.

Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?

FUROSEMIDE 20 MG/2 ML VIAL (NDC 83634030202) is labeled by Avenacy Inc., and CMS classifies it as a generic product.